China biotechs engineer the next generation of oncology therapies

New collaborations involving Henlius, Amberstone, Sanyou Bio and Novocodex highlight efforts to improve the safety, precision and efficacy of two fast-growing oncology modalities, T-cell engagers and antibody-drug conjugates.

Summary from BioWorld Articles.

Coverage 1 article · 1 outlet

1. BioWorld Articles 5h ago
   China biotechs engineer the next generation of oncology therapies ↗